UM

Browse/Search Results:  1-10 of 55 Help

Selected(0)Clear Items/Page:    Sort:
A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer Journal article
Journal of Drug Delivery Science and Technology, 2023,Volume: 79,Page: 103922
Authors:  Wang, Yan;  Zhang, Chen;  Xiao, Meng;  Ganesan, Kumar;  Gao, Fei;  Liu, Qingqing;  Ye, Zhen;  Sui, Yue;  Zhang, Feng;  Wei, Kunhua;  Wu, Yaobin;  Wu, Jianmin;  Du, Bing;  Xu, Cong;  Li, Yan;  Li, Peng;  Zhang, Jinming;  Chen, Jianping
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2023/02/01
Dihydroartemisinin inhibits tumor growth and regulates PD-L1 expression in triple negative breast cancer Conference paper
University of Macau, 2022-12-2
Authors:  Xingan Xing;  Zhiwei Zhou;  Zheng WH(鄭文華)
Microsoft Word | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/12/22
Dihydroartemisinin inhibits tumor growth and regulates PD-L1 expression in triple negative breast cancer Conference paper
Online, 2022-12-11
Authors:  Xingan Xing;  Zhiwei Zhou;  Zheng WH(鄭文華)
Microsoft Word | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/12/22
Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer Journal article
Frontiers in Immunology, 2022,Volume: 13
Authors:  Liu, Xinkui;  Bai, Meirong;  Li, Huiying;  Ye, Peizhi;  Duan, Xiaoxia;  Wu, Chao;  Huang, Zhihong;  Lu, Shan;  Zhang, Jingyuan;  Zhao, Zihan;  Guo, Fengying;  You, Rongli;  Qin, Wenjie;  Wang, Wei;  Han, Aiqing;  Shen, Liangliang;  Wang, Yitao;  Zhao, Zheng;  Luo, Hua;  Wu, Jiarui
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/12/01
4T1 tumor bearing mice  compound kushen injection  single cell RNA-sequencing  T lymphocytes  triple-negative breast cancer  
Dihydroartemisinin inhibits tumor growth and regulates PD-L1 expression in triple negative breast cancer.The 8th Macau Symposium on Biomedical Sciences 2022(2022) Conference paper
University of Macau, 2022-10-14
Authors:  Xingan XING;  Zheng WH(鄭文華)
Microsoft Word | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/12/21
Epigenetics of the Immune Component of Inflammation Journal article
Frontiers in Immunology, 2022
Authors:  Liu, Yan-Jun;  Wang, Haitao;  Zhong, Hai-Jing;  Chong, Cheong-Meng;  Yang, Guan-Jun
Favorite |  | TC[WOS]:1 TC[Scopus]:1 | Submit date:2022/08/12
Cordycepin Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1 Journal article
Frontiers in Oncology, 2022,Volume: 12
Authors:  Wei, Chunli;  Khan, Md Asaduzzaman;  Du, Jiaman;  Cheng, Jingliang;  Tania, Mousumi;  Leung, Elaine Lai Han;  Fu, Junjiang
Favorite |  | TC[WOS]:5 TC[Scopus]:5 | Submit date:2023/01/30
cancer therapeutics  cell migration and invasion  cordycepin  Slug  triple-negative breast cancer (TNBC)  Twist1  
Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin Journal article
eFood, 2022,Volume: 3,Issue: e3
Authors:  Ruting ZHONG;  Mohamed A. Farag;  Meiwan Che;  Chengwei He;  Jianbo Xiao
Adobe PDF | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/07/29
Bioactivities  Fisetin  Molecular Mechanism  Pharmacokinetics  Structure–activity Relationship  
Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy Journal article
Chinese Medicine, 2022,Volume: 17,Issue: 1
Authors:  Zhang, Shuang;  Dong, Yu;  Chen, Xiuping;  Tan, Chris Soon Heng;  Li, Min;  Miao, Kai;  Lu, Jia Hong
Favorite |  | TC[WOS]:1 TC[Scopus]:1 | Submit date:2022/05/31
Apoptosis  Autophagy Inhibition  Irinotecan  Lysosome  Sn-38  Toosendanin  Triple-negative Breast Cancer  
FGFR2–BRD4 Axis Regulates Transcriptional Networks of Histone 3 Modification and Synergy Between Its Inhibitors and PD-1/PD-L1 in a TNBC Mouse Model Journal article
Frontiers in Immunology, 2022,Volume: 13
Authors:  Lei, Josh Haipeng;  Zhang, Lei;  Wang, Zhenyi;  Peltier, Raoul;  Xie, Yusheng;  Chen, Ganchao;  Lin, Shiqi;  Miao, Kai;  Deng, Chu Xia;  Sun, Hongyan
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/05/31
BRD4  epigenetic  FGFR2  immunotherapy  posttranslational modifications  TNBC